PF-06840003

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06840003, covering 2020-01-27 to 2020-01-27. Get the full timeline:

Most recent: Clinical Trial Update: First in Patient Study for PF-06840003 in Malignant Gliomas [Phase 1]